Entera Bio ENTX
NASDAQ ENTX
$2.65 -0.04 (-1.48%)
As of: Sep 30, 2026 · 10:08 AM EDT

Entera Bio (ENTX) Revenue (2019 - 2025)

Updated

Entera Bio's Revenue was $42,000 in FY2025, down 76.8% from $181,000 in FY2024.

Analysis

Entera Bio (ENTX) Revenue (2019 - 2025) Analysis & Trends

From FY2018 onward, Entera Bio has reported Revenue for 6 years.

  • Revenue shows a five-year compound annual growth rate of -35.1% (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Revenue in data going back to FY2018.
  • Per Business Quant data, Revenue in earlier years was $181,000 in FY2024, $134,000 in FY2022 (-76.5%) and $571,000 in FY2021 (+56.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Entera Bio 132.59 Mn 101.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 42,000.00
Dec 31, 2024 82,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 57,000.00
Dec 31, 2022 14,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 44,000.00
Mar 31, 2022 68,000.00
Dec 31, 2021 165,000.00
Sep 30, 2021 140,000.00
Jun 30, 2021 109,000.00
Mar 31, 2021 157,000.00
Jun 30, 2020 52,000.00
Jun 30, 2019 74,000.00
API Access

Entera Bio Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ENTX&period=max&api_key=YOUR_API_KEY